-The Telegraph Centre’s vaccine policy advisers earlier this week approved release of intranasal vaccine into the private market New Delhi: Indian vaccine maker Bharat Biotech announced on Tuesday that its intranasal Covid-19 vaccine, approved by the Centre as a booster dose, would be available at private hospitals for Rs 800 plus additional taxes and service charges per dose. People 18 years or older who have taken two doses of Covaxin, Covishield or any...
More »SEARCH RESULT
Total Matching Records found : 25
Covaxin approval sparks questions and clarifications -Rhythma Kaul
-Hindustan Times On November 15, Boston-based health news website Stat News cited official documents that purported to detail a series of problems in how Bharat Biotech’s coronavirus vaccine, funded partly by the government, was approved. The Union government and vaccine maker Bharat Biotech on Thursday refuted a report that alleged rules and protocols were bent during the approval process for Covaxin, but the clarifications served to further add to the questions that...
More »Covishield, Covaxin to now cost private hospitals Rs 225 per dose -Milan Sharma
-IndiaToday.in Private hospitals will now be able to buy a single dose of Covid-19 vaccines Covishield and Covaxin at Rs 225. A single dose of the Serum Institute of India's Covishield and Bharat Biotech's Covaxin will now cost private hospitals Rs 225. Private hospitals will charge Rs 150 for administering the dose. Adar Poonawalla, CEO of SII, said in a tweet on Saturday that the vaccine maker has decided to slash the prices...
More »Second jab overdue for 19 lakh, figures fox health officials -Subhajoy Roy
-The Telegraph Those who have crossed the maximum advised gap between two doses of Covid vaccines are counted in the list of overdue doses, said another health department official There are more than 19 lakh people in Bengal who have not taken their second doses despite the due dates to take them getting over. Some of them have claimed that they took two doses at separate centres. But the authorities are not asking for...
More »Bharat Biotech yet to start supply of May order of Covaxin: Centre
-The Hindu Health Ministry provides break-up of expected vaccine delivery schedule to Supreme Court Bharat Biotech is yet to begin supply for a batch of vaccines, an order for which was placed by the Health Ministry in May, according to an affidavit filed by the Ministry in the Supreme Court on Saturday. The Health Ministry told the apex court that it expected to receive at least 51 crore doses from January-July. Thirty two...
More »
